sarita kumari

Dr. sarita kumari

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2021 in Indian Journal of Gynecologic Oncology
Verified
Journal Article
Closed access
PDF file
NBNeerja Bhatla
Neerja Bhatla
JMJyoti Meena
Jyoti Meena
SKsarita kumari
sarita kumari
DBDipanwita Banerjee
Dipanwita Banerjee
PSPrerana Singh
Prerana Singh
JNJayashree Natarajan
Jayashree Natarajan

1 May 2021 in Gynecologic Oncology Reports
Verified
Journal Article
Open access
SKsarita kumari
sarita kumari
SKSunesh Kumar
Sunesh Kumar
NBNeerja Bhatla
Neerja Bhatla
SMSandeep Mathur
Sandeep Mathur
STSanjay Thulkar
Sanjay Thulkar
LKLalit Kumar
Lalit Kumar
• In BOT Fertility sparing surgery is a safe procedure in early stage disease and should be performed in a young patient. • Recurrences are more common in the cystectomy group as compared to oophorectomy (33% vs 6.2%; p = 0.03). • Overall and Recurrence free survival is favourable and recurrences are always salvaged by surgery. • Spontaneous conception and live birth rates after fertility sparing surgery in patients with BOT are modest (50%).

17 October 2023 in Oncology Reviews
Verified
Journal Article
Open access
SKsarita kumari
sarita kumari
Cervical cancer remains a leading cause of cancer related morbidity and mortality in low/low-middle income countries. Lack of screening is the leading cause of cases being diagnosed in advanced stages and screening is still opportunistic in a majority of these countries. Hospital visits during pregnancy provides a window of opportunity to screen these susceptible women and reduce the burden of disease. Screening women during pregnancy is not practiced widely due to concerns of pregnancy loss, bleeding and a lack of clear information among patients as well as healthcare professionals.

1 December 2023 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
RRRakhi Rai
Rakhi Rai
RSRohini Sehgal
Rohini Sehgal
SSSeema Singhal
Seema Singhal
VSVanita Suri
Vanita Suri
PSPoonam Shivkumar
Poonam Shivkumar
NBNeerja Bhatla
Neerja Bhatla
Objectives: The 70% screening coverage target proposed in the global cervical cancer elimination strategy is not achieved even at tertiary centres in India. A situational analysis was done to assess the currently existing facilities and barriers in tertiary care institutes. Methods: This cross sectional multicentric study was conducted from August to September 2021 in six tertiary care institutes across India. Women aged 30-49 years attending outpatient services (OPD) were invited for cervical screening. Women and health care professionals (HCPs) were administered structured questionnaires to assess knowledge, attitude and practices regarding cervical cancer screening services. Results: Out of 6709 eligible women who attended OPD, 1666 (24.8%; range:19-57%) received screening. Availability of screening kits was limited to 10-25 Pap/HPV tests per day. Visual inspection with acetic acid (VIA) and HPV testing were offered only at certain centres. Colposcopy and treatment facilities were optimal at all centres. Knowledge, attitude and practices were analysed for 1800 women: 45.7% had heard of cervical cancer, 78.0% did not know that it is preventable, 75.8% never heard about screening. Common symptoms correctly identified included postmenopausal bleeding (4.8%), postcoital bleeding (5.7%), intermenstrual bleeding (5.8%) and vaginal discharge (12.4%). Risk factors were identified by minority: poor menstrual hygiene (6.6%), oral contraceptive pill use (6.4%), multiparity (4.4%), and HPV infection (3.0%). Out of 21, mean total knowledge score (MTKS) was 2.07± 2.67. Out of 317 HCPs, 96.5% knew that cervical cancer is caused by HPV infection, is preceded by premalignant stage, and that it is preventable by screening and treatment (80.1%). Knowledge about screening modalities was present in 87.4% for cytology, 75.1% for VIA, 68.8% for HPV test. MTKS of HCPs was 20.88±6.61 out of 32. Conclusion: Even at tertiary centres, limited availability of HPV tests, reluctance to implement VIA and lack of awareness among women remain the major barriers.

8 October 2024 in Oncology Reviews
Verified
Journal Article
Open access
PDF file
RCRudrika Chandra
Rudrika Chandra
SKsarita kumari
sarita kumari
In the current era, environmental factors are well established as major causative agents for all cancers especially lung and breast cancer. We sought to review the current available literature on the topic pertaining to gynaecologic cancers. Although a few factors are well established in literature, others need more research to conclude.

7 August 2024 in Indian Journal of Gynecologic Oncology
Verified
Journal Article
Closed access
PDF file
KUKovuri Umadevi
Kovuri Umadevi
Dola SundeepDola Sundeep
Dola Sundeep
ALA. Mercy Latha
A. Mercy Latha
SKsarita kumari
sarita kumari
EKEswaramoorthy KV
Eswaramoorthy KV
AKAlluru Gopala Krishna
Alluru Gopala Krishna